Baxter International | BAX - Capital De Empréstimo

Preço das Ações
16.91
Mudança Diária
-1.03 -5.74%
Mensal
7.03%
Anual
-45.75%
Q2 Previsão
17.77




Capital De Empréstimo Alterar Data
Abbott USD 29.64B 19.74B 2026-03
AngioDynamics USD 5.6M 100K 2025-09
Artivion USD 217.81M 2.94M 2025-12
AtriCure USD 61.86M 0 2025-12
Avanos Medical USD 90.3M 3.1M 2025-12
Baxter International USD 9.47B 726M 2025-12
Becton, Dickinson and Co. USD 16.92B 705M 2025-12
Boston Scientific USD 11.01B 19M 2025-12
Cooper Companies USD 1.88B 578.5M 2025-12
Dexcom USD 1.24B 53.6M 2025-12
Edwards Lifesciences USD 600M 1.7M 2026-03
Fresenius EUR 10.8B 1.49B 2025-09
Globus Medical USD 436K 9K 2025-12
Halozyme Therapeutics USD 2.14B 1.34B 2025-12
ICU Medical USD 1.27B 48.01M 2025-12
Inogen USD 0 0 2022-06
Insulet USD 930.8M 4.1M 2025-12
Integra LifeSciences USD 1.86B 63.76M 2025-12
Intuitive Surgical USD 0 0 2025-03
J&J USD 37.53B 1.91B 2026-03
Laboratory Of America USD 5.15B 800K 2025-12
Masimo USD 518M 41.1M 2025-12
Medtronic USD 27.88B 255M 2025-12
Merit Medical Systems USD 734.04M 1.12M 2025-12
Quest Diagnostics USD 5.16B 12M 2026-03
Smith & Nephew USD 3.3B 22M 2025-12
Stryker USD 14.86B 14M 2025-12
Tandem Diabetes Care USD 310.04M 446K 2025-12
Teleflex USD 2.54B 30.06M 2025-12
Terumo JPY 99.9B 12M 2025-12
Zimmer Biomet Holdings USD 6.3B 636.9M 2026-03